What is he best known for?
The fields of study he is best known for:
- Enzyme
- Gene
- Internal medicine
His main research concerns Antibiotics, Microbiology, Antibacterial agent, Pharmacology and Aminoglycoside.
His Antibiotics study combines topics in areas such as Pharmacodynamics, Drug resistance and Biological activity.
Paul M. Tulkens interconnects Extracellular, Staphylococcus aureus, Efflux, Intracellular and Oritavancin in the investigation of issues within Microbiology.
His work is dedicated to discovering how Antibacterial agent, Internal medicine are connected with Endocrinology and other disciplines.
His Pharmacology research integrates issues from Ciprofloxacin, Nephrotoxicity, Intensive care medicine, Tissue concentrations and Tissue distribution.
His studies in Aminoglycoside integrate themes in fields like Streptomycin, Amikacin and Phospholipidosis.
His most cited work include:
- Commentary. Lysosomotropic agents. (1554 citations)
- Aminoglycosides: Activity and Resistance (797 citations)
- Tackling antibiotic resistance (650 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Microbiology, Antibiotics, Pharmacology, Aminoglycoside and Antibacterial agent.
His Microbiology study combines topics in areas such as Pseudomonas aeruginosa, Efflux, Intracellular and Staphylococcus aureus.
His research integrates issues of Bacteria, Biofilm and Drug resistance in his study of Antibiotics.
His Pharmacology research includes themes of In vivo and Toxicity, Nephrotoxicity.
Paul M. Tulkens combines subjects such as Phospholipidosis, Phospholipid, Kidney and Gentamicin with his study of Aminoglycoside.
His Antibacterial agent study typically links adjacent topics like Oritavancin.
He most often published in these fields:
- Microbiology (31.21%)
- Antibiotics (22.93%)
- Pharmacology (21.99%)
What were the highlights of his more recent work (between 2009-2021)?
- Microbiology (31.21%)
- Antibiotics (22.93%)
- Staphylococcus aureus (12.53%)
In recent papers he was focusing on the following fields of study:
Microbiology, Antibiotics, Staphylococcus aureus, Pseudomonas aeruginosa and Linezolid are his primary areas of study.
Paul M. Tulkens has included themes like Extracellular, Intracellular and Bacteria in his Microbiology study.
His studies deal with areas such as Pharmacodynamics, Intensive care medicine, Pharmacology and Biofilm as well as Antibiotics.
His Pharmacology study combines topics from a wide range of disciplines, such as Flucloxacillin and In vivo.
His research in Staphylococcus aureus intersects with topics in Delafloxacin and Antibacterial agent.
His Antibacterial agent course of study focuses on Pharmacotherapy and Hepatobiliary disease.
Between 2009 and 2021, his most popular works were:
- Tackling antibiotic resistance (650 citations)
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin against Staphylococcus aureus (120 citations)
- Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data (113 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Gene
- Internal medicine
His scientific interests lie mostly in Microbiology, Staphylococcus aureus, Antibiotics, Antibacterial agent and Pharmacology.
His biological study spans a wide range of topics, including Pseudomonas aeruginosa, Bacteria, Efflux and Extracellular.
His Staphylococcus aureus research is multidisciplinary, relying on both Delafloxacin and Listeria monocytogenes.
The various areas that Paul M. Tulkens examines in his Antibiotics study include Potency and Intensive care medicine.
His study in Antibacterial agent is interdisciplinary in nature, drawing from both Continuous infusion and Doripenem.
His research on Pharmacology often connects related topics like Flucloxacillin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
